MediXall Group, Inc.: 10-Q filed 2024-06-20

Name: MediXall Group, Inc.: 10-Q filed 2024-06-20
Creator: MediXall Group, Inc.

What MediXall Group, Inc. reported in its quarterly report filed 2024-06-20 (fiscal Q3 2023): 30 published measures, 97 facts as tagged in accession 0001079973-24-000912.

This filing

Form: 10-Q (quarterly report)
Filed: 2024-06-20
Fiscal period: fiscal Q3 2023
Accession: 0001079973-24-000912 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MediXall Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2023-09-30	455,501	USD
At 2022-12-31	862,013	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2023-09-30	5,704,356	USD
At 2022-12-31	4,531,378	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2023-09-30	-5,248,855	USD
At 2023-06-30	-4,838,117	USD
At 2023-03-31	-4,372,502	USD
At 2022-12-31	-3,669,365	USD
At 2022-09-30	-2,916,273	USD
At 2022-06-30	-1,764,445	USD
At 2022-03-31	-675,495	USD
At 2021-12-31	-340,122	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-908,067	USD	92
2023-01-01 to 2023-09-30	-3,108,940	USD	273
2023-04-01 to 2023-06-30	-979,378	USD	91
2023-01-01 to 2023-03-31	-1,221,495	USD	90
2022-07-01 to 2022-09-30	-1,083,878	USD	92
2022-01-01 to 2022-09-30	-5,047,974	USD	273
2022-04-01 to 2022-06-30	-1,553,994	USD	91
2022-01-01 to 2022-03-31	-2,410,102	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	-1,028,100	USD	273
2022-01-01 to 2022-09-30	-2,962,802	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	65,535	USD	92
2023-01-01 to 2023-09-30	214,925	USD	273
2022-07-01 to 2022-09-30	20,766	USD	92
2022-01-01 to 2022-09-30	39,025	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	1,034,351	USD	273
2022-01-01 to 2022-09-30	2,974,962	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2023-09-30	-35,721,745	USD
At 2022-12-31	-32,612,805	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	130,487,491	shares	92
2023-01-01 to 2023-09-30	126,048,154	shares	273
2022-07-01 to 2022-09-30	116,886,659	shares	92
2022-01-01 to 2022-09-30	115,896,191	shares	273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	130,487,491	shares	92
2023-01-01 to 2023-09-30	126,048,154	shares	273
2022-07-01 to 2022-09-30	116,886,659	shares	92
2022-01-01 to 2022-09-30	115,896,191	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-0.01	USD/shares	92
2023-01-01 to 2023-09-30	-0.03	USD/shares	273
2022-07-01 to 2022-09-30	-0.01	USD/shares	92
2022-01-01 to 2022-09-30	-0.05	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-0.01	USD/shares	92
2023-01-01 to 2023-09-30	-0.03	USD/shares	273
2022-07-01 to 2022-09-30	-0.01	USD/shares	92
2022-01-01 to 2022-09-30	-0.05	USD/shares	273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2023-07-01 to 2023-09-30	USD	92
2023-01-01 to 2023-09-30	USD	273
2022-07-01 to 2022-09-30	USD	92
2022-01-01 to 2022-09-30	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2023-09-30	14,684	USD
At 2022-12-31	21,755	USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2023-09-30	13,151	USD
At 2022-12-31	11,499	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	37,002	USD	92
2023-01-01 to 2023-09-30	171,837	USD	273
2022-07-01 to 2022-09-30	0	USD	92
2022-01-01 to 2022-09-30	0	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2023-09-30	5,704,356	USD
At 2022-12-31	4,341,921	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2023-09-30	136,500	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	910,492	USD	92
2023-01-01 to 2023-09-30	3,135,769	USD	273
2022-07-01 to 2022-09-30	1,104,644	USD	92
2022-01-01 to 2022-09-30	5,086,999	USD	273

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	2,425	USD	92
2023-01-01 to 2023-09-30	26,829	USD	273
2022-07-01 to 2022-09-30	20,766	USD	92
2022-01-01 to 2022-09-30	39,025	USD	273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	63,110	USD	92
2023-01-01 to 2023-09-30	188,096	USD	273
2022-07-01 to 2022-09-30	0	USD	92
2022-01-01 to 2022-09-30	0	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2023-09-30	130,487,491	shares
At 2022-12-31	122,187,491	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2023-09-30	9,667	USD
At 2022-12-31	3,416	USD
At 2022-09-30	75,578	USD
At 2021-12-31	63,418	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2023-09-30	30,338,317	USD
At 2022-12-31	28,817,084	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2023-09-30	0	USD
At 2022-12-31	260,177	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2023-09-30	291,166	USD
At 2022-12-31	412,582	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-908,067	USD	92
2023-01-01 to 2023-09-30	-3,108,940	USD	273
2022-07-01 to 2022-09-30	-1,083,878	USD	92
2022-01-01 to 2022-09-30	-5,047,974	USD	273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2023-07-01 to 2023-09-30	-987,063	USD	92
2023-01-01 to 2023-09-30	-3,343,350	USD	273
2022-07-01 to 2022-09-30	-1,162,873	USD	92
2022-01-01 to 2022-09-30	-5,282,384	USD	273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	0	USD	273
2022-01-01 to 2022-09-30	0	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2023-01-01 to 2023-09-30	1,853	USD	273
2022-01-01 to 2022-09-30	760,500	USD	273

Inspect the source

Entity: MediXall Group, Inc. / CIK 0001601280
Captured: 2026-09-21T17:20:21.643Z
SEC response SHA-256: b6322b58d999c8a74b96274fe9d2bf7196a7223cedbe45a09c2d28d5c34a5827

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001601280.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))